Sign up to receive updates about our work in Health.

Access to Medicines

Access to Medicines

Despite advances in medical science, affordable safe and effective medicines remain inaccessible to billions of people worldwide. The Open Society Foundations support efforts to increase access to essential medicines for people in low-resource countries, especially for poor and marginalized populations.

Learn More

Contact Us

Questions about our work on this topic? Please use this contact box.

Programs

The following Open Society programs focus on this topic.

More on the ideas and programs behind our work: Access to Medicines. Hide info

Recent Work

Voices
Women Speak Up Against an Archaic Abortion Law in Northern Ireland

Why is it still illegal to take a pill the World Health Organization calls an essential medicine?

Voices
A New Look Behind the Pricing of a $1,000 Pill

A U.S. Senate investigation concludes that a blockbuster hepatitis C drug was priced to drive profits, not innovation. But that’s just the tip of the iceberg.

Report
The Impact of International Drug Policy on Access to Controlled Medicines

This report outlines the significant impact the international drug conventions have on access to controlled medicines, and sets out some recommendations for a meaningful debate at the UNGASS in 2016.

Voices
Only a Radical Overhaul of the System Can Reclaim Medicines for the Public Interest

The pharmaceutical industry isn’t delivering innovation the public needs—but drug makers are reaping the profits they demand. It’s time to rethink the system.

Voices
Ukraine’s Deadly Medicines Bottleneck

With the government turning its back on regions it has lost control of, dwindling medicine stockpiles in Ukraine threaten the lives of thousands.

Briefing Paper
Access to Medicines and the Global Fund

There are growing concerns that the Global Fund to Fight AIDS, TB, and Malaria is fundamentally altering its approach to access to medicines. This briefing paper explores five key areas that illustrate these concerns.

Open Society People

Project Director, Access to Medicines
Open Society Foundations–New York, Public Health Program